Real-time enrollment status for this major depressive disorder clinical trial
Current Status
Recruiting
Checked: July 14, 2026 at 4:32 PM UTC
| NCT Number | NCT07276997 |
| Recruiting Status | Recruiting |
| Condition | Major Depressive Disorder |
| Phase | PHASE2 |
| Target Enrollment | 195 participants |
| Active Locations | 33 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | June 15, 2026 (4 weeks ago) |
As of July 14, 2026: Clinical trial NCT07276997 is currently recruiting participants. This phase2 study for major depressive disorder is actively seeking new participants at 33 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07276997 is actively recruiting participants as of July 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07276997 was last updated 4 weeks ago (June 15, 2026). HelloStudys verifies this status automatically.